These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15065087)

  • 1. No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer.
    Platz EA; De Marzo AM; Erlinger TP; Rifai N; Visvanathan K; Hoffman SC; Helzlsouer KJ
    Prostate; 2004 Jun; 59(4):393-400. PubMed ID: 15065087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and colorectal adenoma in the CLUE II cohort.
    Tsilidis KK; Erlinger TP; Rifai N; Hoffman S; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
    Cancer Causes Control; 2008 Aug; 19(6):559-67. PubMed ID: 18214695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
    Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein concentrations and subsequent ovarian cancer risk.
    McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
    Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk.
    Platz EA; Helzlsouer KJ; Hoffman SC; Morris JS; Baskett CK; Comstock GW
    Prostate; 2002 Sep; 52(4):288-96. PubMed ID: 12210489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer.
    Li H; Kantoff PW; Ma J; Stampfer MJ; George DJ
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1557-61. PubMed ID: 15941972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
    Lilja H; Ulmert D; Björk T; Becker C; Serio AM; Nilsson JA; Abrahamsson PA; Vickers AJ; Berglund G
    J Clin Oncol; 2007 Feb; 25(4):431-6. PubMed ID: 17264339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking and risk of prostate cancer in middle-aged men.
    Plaskon LA; Penson DF; Vaughan TL; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):604-9. PubMed ID: 12869398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cancer.
    Berndt SI; Carter HB; Landis PK; Hallfrisch J; Rohrmann S; Metter EJ; Platz EA
    Nutrition; 2005 Jun; 21(6):686-90. PubMed ID: 15925292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.
    Kurahashi N; Iwasaki M; Inoue M; Sasazuki S; Tsugane S
    J Clin Oncol; 2008 Dec; 26(36):5923-9. PubMed ID: 19018085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluation.
    Michael A; Stephan C; Kristiansen G; Burckhardt M; Loening SA; Schnorr D; Jung K
    Prostate; 2005 Jan; 62(1):34-9. PubMed ID: 15389818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and the risk of prostate cancer.
    Porter MP; Stanford JL
    Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
    Rodriguez C; Freedland SJ; Deka A; Jacobs EJ; McCullough ML; Patel AV; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):63-9. PubMed ID: 17179486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III).
    Rohrmann S; De Marzo AM; Smit E; Giovannucci E; Platz EA
    Prostate; 2005 Jan; 62(1):27-33. PubMed ID: 15389816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
    Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
    J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and the risk of prostate cancer in Italy.
    Tavani A; Gallus S; Bertuzzi M; Dal Maso L; Zucchetto A; Negri E; Franceschi S; Ramazzotti V; Montella M; La Vecchia C
    Eur Urol; 2005 Mar; 47(3):313-7; discussion 317. PubMed ID: 15716192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate biopsy: who, how and when. An update.
    Djavan B; Milani S; Remzi M
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.